Vladimir Tolmachev
- Radiology, Nuclear Medicine and Imaging top 0.02%
- Oncology top 0.2%
- Molecular Biology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 5%
- Co-authors
- Anna OrlovaJoachim FeldwischMattias SandströmHans LundqvistJörgen CarlssonAnders WennborgFredrik NilssonLars Abrahmsén
- Topics
- Radiopharmaceutical Chemistry and Applications (280 papers)Monoclonal and Polyclonal Antibodies Research (229 papers)HER2/EGFR in Cancer Research (116 papers)
- Partner nations
- SwedenRussiaUnited States
In The Last Decade
Vladimir Tolmachev
384 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Radiology, Nuclear Medicine and Imaging 9.4k
- Oncology 4.9k
- Molecular Biology 4.0k
- Pulmonary and Respiratory Medicine 1.4k
- Immunology 668
Countries citing papers authored by Vladimir Tolmachev
This map shows the geographic impact of Vladimir Tolmachev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Tolmachev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Tolmachev more than expected).
Fields of papers citing papers by Vladimir Tolmachev
This network shows the impact of papers produced by Vladimir Tolmachev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Tolmachev. The network helps show where Vladimir Tolmachev may publish in the future.
Co-authorship network of co-authors of Vladimir Tolmachev
This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Tolmachev. A scholar is included among the top collaborators of Vladimir Tolmachev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Tolmachev. Vladimir Tolmachev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 13 | |
| 9 | 0 | |
| 10 | 3 | |
| 11 | 4 | |
| 12 | 11 | |
| 13 | 11 | |
| 14 | 8 | |
| 15 | 25 | |
| 16 | 19 | |
| 17 | GMP compliant preparation of a (68)Gallium-labeled Affibody analogue for breast cancer patient examination : first-in-man | 3 |
| 18 | 81 | |
| 19 | 36 | |
| 20 | Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. | 73 |
About Vladimir Tolmachev
Vladimir Tolmachev is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine, having authored 401 papers that have together received 11.9k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (280 papers), Monoclonal and Polyclonal Antibodies Research (229 papers) and HER2/EGFR in Cancer Research (116 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (9.4k citations), Oncology (4.9k citations) and Molecular Biology (4.0k citations). Vladimir Tolmachev has collaborated with scholars based in Sweden, Russia and United States. Frequent co-authors include Anna Orlova, Joachim Feldwisch, Mattias Sandström, Hans Lundqvist, Jörgen Carlsson, Anders Wennborg, Fredrik Nilsson, Lars Abrahmsén, Fredrik Y. Frejd and Stefan Ståhl. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.